Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
210 Leser
Artikel bewerten:
(0)

Augmentum Fintech Plc - IPO - Successful Fundraising

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR TO US PERSONS. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM PART OF, AND SHOULD NOT BE CONSTRUED AS, AN OFFER FOR SALE OR SUBSCRIPTION OF, OR SOLICITATION OF ANY OFFER TO BUY OR SUBSCRIBE FOR, ANY ORDINARY SHARES IN THE COMPANY, IN ANY JURISDICTION, INCLUDING THE UNITED STATES, NOR SHALL IT, OR ANY PART OF IT, OR THE FACT OF ITS DISTRIBUTION, FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH, ANY CONTRACT OR INVESTMENT DECISION WHATSOEVER, IN ANY JURISDICTION. THIS ANNOUNCEMENT DOES NOT CONSTITUTE A RECOMMENDATION REGARDING ANY SECURITIES. ANY INVESTMENT DECISION MUST BE MADE EXCLUSIVELY ON THE BASIS OF THE PROSPECTUS PUBLISHED BY THE COMPANY IN CONNECTION WITH THE ISSUE.

9 March 2018

Augmentum Fintech plc

("Augmentum Fintech" or the "Company")

INITIAL PUBLIC OFFERING ("IPO") - SUCCESSFUL FUNDRAISING OF £94 MILLION

Further to the Prospectus issued by the Company on 22 February 2018, the Board of Directors of Augmentum Fintech plc, a new closed-ended investment company which will invest in private financial services technology businesses in the UK and Europe, is pleased to announce that it has raised a total of £94 million in its IPO pursuant to a Placing, Offer for Subscription, Intermediaries Offer and the issue of Consideration Shares at a price of £1 per Ordinary Share.

On Admission, the Management Team and family members will in aggregate hold 3.6% of the issued share capital of the Company.

Application has been made for 94,000,000 Ordinary Shares to be admitted to the premium listing segment of the Official List of the FCA and to trading on the main market of the London Stock Exchange ("Admission"). It is expected that Admission will become effective and that unconditional dealings in the Ordinary Shares will commence at 8:00 a.m. on Tuesday, 13 March 2018.

The Company's investment objective is to generate capital growth over the long term through investment in a focused portfolio of fast growing and/or high potential private financial services technology businesses based predominantly in the UK and wider Europe.

Fidante Capital acted as Sole Financial Adviser, Bookrunner and Joint Sponsor in relation to the Issue.

Commenting on the result of the Issue, Neil England, Chairman of Augmentum Fintech plc, said:

"We are pleased with the response which Augmentum Fintech has received on its IPO, with strong support from a broad range of investors. The combination of an established, successful and hands-on management team with access to an attractive seed portfolio as well as an identified and growing pipeline of investments in the fintech space, makes this a compelling investment. We welcome our new shareholders and look forward to working with them and successfully delivering on our investment strategy."

Tim Levene, co-founder and principal of Augmentum Capital, the Company's Investment Adviser, commented:

"The Company is well positioned to capitalise on the substantial demand for post-seed venture funding in the UK and wider Europe fintech market. We will continue carefully to curate a portfolio of high quality, compelling fintech investments and actively drive value creation at each business to deliver attractive risk adjusted returns over the long term for our new investors."

Dealing Codes and Total Voting Rights

The dealing codes for the Ordinary Shares are as follows:

ISINGB00BG12XV81
SEDOLBG12XV8
TickerAUGM

The total number of Ordinary Shares with voting rights in issue immediately following Admission will be 94,000,000 Ordinary Shares.

Capitalised terms shall have the meaning attributed to them in the IPO Prospectus published by the Company on 22 February 2018 unless otherwise defined in this announcement.

FOR FURTHER INFORMATION ON THE COMPANY, PLEASE CONTACT:

Augmentum
Tim Levene
Richard Matthews
info@augmentumcapital.com or via Newgate below
Fidante Capital (Sole Financial Adviser, Bookrunner and Joint Sponsor)
Tom Skinner
Nick Donovan
Katie Standley
+44 (0) 20 7832 0900
Solid Solutions (Intermediaries Offer Adviser)
Nigel Morris
+44 (0) 20 7549 1613
intermediaries@solid-solutions.co.uk
Newgate Communications (PR Adviser)
James Benjamin
Alistair Kellie
Anna Geffert
+44 (0) 20 7680 6550
augmentum@newgatecomms.com

Further information on the Company can be found on its website at www.augmentumfintech.com.

The Company's LEI is: 213800OTQ44T555I8S71.

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2018 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.